Authors
Latest:
Why Data Integrity Should be an Integral Part of the Pharma Biotech Industry CultureData integrity is the essence of GMP, the cornerstone of how the industry operates, and it is vital that all organizations embrace it to survive the rapidly changing life sciences landscape.
Latest:
Categorical Data AnalysisA review of different statistical methods for data types and models used during research.
Latest:
Evolution of Clinical Trial Agreement Review in Malaysia Through Clinical Research MalaysiaA reduction of Clinical Trial Agreement Review times has caused rapid development in Malaysian clinical trials.
Latest:
Evolution of Clinical Trial Agreement Review in Malaysia Through Clinical Research MalaysiaA reduction of Clinical Trial Agreement Review times has caused rapid development in Malaysian clinical trials.
Latest:
Advancing Oncology Drug Development with ePRO SolutionsFor drug developers, oncology therapeutics arguably represent both the greatest opportunity and challenge for putting patients at the center. This ebook covers series strategies for Advancing Oncology Drug Development with ePRO Solutions.
Latest:
How Data and Analytics Can Improve Clinical Trial FeasibilityThese seven key building blocks for success are outlined to help companies develop and implement a data-and-analytics-driven approach to clinical trial feasibility.
Latest:
4 Key Actions ClinOps Can Take Now to Avoid DisruptionsBiopharmaceutical sponsors should make urgent decisions now to plan for continued clinical research in the coming months.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance PerspectiveThis article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
Risk-Based Monitoring Versus Source Data VerificationPilot study compares a risk-based monitoring and remote trial management method with traditional on-site source data verification for trial oversight.
Latest:
Comparing Risk Based Monitoring and Remote Trial Management vs. SDVA new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.
Latest:
The Evolving Relationship Between Sponsors and Contract Research OrganizationsIf the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at ICON, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.
Latest:
Human Centered Design—A Pathway to Patient CentricityuMotif worked with IDEO to shape a patient-centric approach by focusing on human-centered design.
Latest:
Patient Centricity: The Journey MattersFive proactive steps industry can take to optimize a patient's clinical trial experience.
Latest:
Alzheimer’s Clinical Trials: Obstacles and OpportunitiesFor sponsors who are pursuing the goal of treating Alzheimer’s disease, understanding the obstacles inherent in Alzheimer’s clinical trials can help in planning for, and overcoming, these challenges.
Latest:
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsCell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
Latest:
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsCell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
Latest:
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsCell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
Latest:
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsCell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
